NeOnc Technologies Holdings(NTHI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NTHI NeOnc Technologies Holdings

交易中 03-11 09:50:49 EDT

9.61

+0.19

+1.96%

最高9.61	最低9.30	成交量3,572
今开9.39	昨收9.42	日振幅3.29%
总市值2.18亿	流通市值7,940万	总股本2,269万
成交额3.37万	换手率0.04%	流通股本826.64万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NTHI","market":"US","secType":"STK","nameCN":"NeOnc Technologies Holdings","latestPrice":9.605,"timestamp":1773236962908,"preClose":9.42,"halted":0,"volume":3572,"delay":0,"changeRate":0.01963906581740982,"floatShares":8266400,"shares":22692159,"eps":-2.5859,"marketStatus":"交易中","change":0.185,"latestTime":"03-11 09:50:49 EDT","open":9.39,"high":9.605,"low":9.295,"amount":33723.5199,"amplitude":0.032909,"askPrice":9.93,"askSize":100,"bidPrice":9.28,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-2.5859,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773259200000},"marketStatusCode":2,"adr":0,"listingDate":1711512000000,"exchange":"NASDAQ","adjPreClose":9.42,"postHourTrading":{"tag":"盘后","latestPrice":9.42,"preClose":9.42,"latestTime":"16:55 EDT","volume":157,"amount":1477.75,"timestamp":1773176117803,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.692533},"requestUrl":"/m/hq/s/NTHI","defaultTab":"news","newsList":[{"id":"1115650367","title":"Neonc Technologies公布口服Neo212一期剂量递增试验结果：确定二期推荐剂量 管理层将于美东时间上午9点召开KOL电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1115650367","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115650367?lang=zh_cn&edition=full","pubTime":"2026-03-04 21:03","pubTimestamp":1772629426,"startTime":"0","endTime":"0","summary":"Neonc Technologies Holdings宣布口服抗癌药物Neo212的一期临床试验剂量递增阶段数据。研究明确了药物的安全剂量范围与毒性特征，并成功确定了二期临床试验推荐使用剂量。\n公司管理层将于美东时间今日上午9点举办关键意见领袖电话会议，深入解读临床数据及后续开发计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1191348497","title":"Neonc Technologies获Cinctive Capital Management领投1000万美元战略PIPE投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1191348497","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191348497?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:01","pubTimestamp":1769781715,"startTime":"0","endTime":"0","summary":"Neonc Technologies Holdings成功获得由Cinctive Capital Management主导的战略性PIPE（私募股权投资公开股）融资，其中Cinctive Capital Management单独注资1000万美元。此次投资将强化Neonc Technologies在医疗科技领域的研发能力与市场扩张步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1162930745","title":"NeOnc Technologies Holdings：向市场提交出售最多111,732股普通股的招股说明书","url":"https://stock-news.laohu8.com/highlight/detail?id=1162930745","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162930745?lang=zh_cn&edition=full","pubTime":"2025-12-24 06:10","pubTimestamp":1766527827,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings：向市场提交出售最多111,732股普通股的招股说明书","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1174332497","title":"NeOnc Technologies Holdings - 持续使用Neo100鼻用剂量未显示显著毒性","url":"https://stock-news.laohu8.com/highlight/detail?id=1174332497","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174332497?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:10","pubTimestamp":1762953033,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings - 持续使用Neo100鼻用剂量未显示显著毒性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1132787745","title":"NeOnc Technologies Holdings 达到44%的六个月无进展生存率，超越基准","url":"https://stock-news.laohu8.com/highlight/detail?id=1132787745","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132787745?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:10","pubTimestamp":1762953014,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings 达到44%的六个月无进展生存率，超越基准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1110626785","title":"Neonc Technologies任命Amir Heshmatpour为首席执行官，以推动临床和企业增长的下一个阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1110626785","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110626785?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:02","pubTimestamp":1762264952,"startTime":"0","endTime":"0","summary":"Neonc Technologies任命Amir Heshmatpour为首席执行官，以推动临床和企业增长的下一个阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1173476652","title":"NeOnc Technologies Holdings子公司Nuromena与M42旗下Iros签署主服务协议并扩充董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1173476652","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173476652?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:01","pubTimestamp":1760014893,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings旗下子公司Nuromena日前与M42公司的Iros部门签署了主服务协议，同时宣布扩充其董事会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1141015679","title":"NeOnc Technologies Holdings任命杜克大学Preston Robert Tisch脑肿瘤中心主任David M. Ashley博士加入科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1141015679","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141015679?lang=zh_cn&edition=full","pubTime":"2025-10-02 21:02","pubTimestamp":1759410144,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings宣布任命David M. Ashley博士加入其科学顾问委员会，Ashley博士现任杜克大学Preston Robert Tisch脑肿瘤中心主任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"1170203781","title":"NeOnc Technologies欢迎NYU Langone Health's Perlmutter Cancer Center神经肿瘤科主任兼脑脊髓肿瘤中心联席主任Alexandra M. Miller博士加入科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1170203781","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170203781?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:04","pubTimestamp":1759323845,"startTime":"0","endTime":"0","summary":"NeOnc Technologies宣布欢迎Alexandra M. Miller博士加入其科学顾问委员会。Miller博士现任NYU Langone Health's Perlmutter Cancer Center神经肿瘤科主任兼脑脊髓肿瘤中心联席主任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"1161308975","title":"NeOnc Technologies Holdings任命知名神经肿瘤学家Henry S. Friedman博士加入科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1161308975","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161308975?lang=zh_cn&edition=full","pubTime":"2025-09-29 21:01","pubTimestamp":1759150873,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings任命知名神经肿瘤学家Henry S. Friedman博士加入科学顾问委员会","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0},{"id":"2566295556","title":"Neonc Technologies Holdings, Inc.盘中异动 股价大涨6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566295556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566295556?lang=zh_cn&edition=full","pubTime":"2025-09-10 22:42","pubTimestamp":1757515353,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日22时42分，Neonc Technologies Holdings, Inc.股票出现波动，股价快速上涨6.13%。Neonc Technologies Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Galecto, Inc.、Camp4 Therapeutics Corporation、Cdt Equity Inc C/Wts 22/09/2028涨幅较大，Revelation Biosciences, Inc.、Cdt Equity Inc.、Camp4 Therapeutics Corporation较为活跃，换手率分别为700.47%、198.40%、165.33%，振幅较大的相关个股有Camp4 Therapeutics Corporation、Galecto, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为59.30%、47.67%、37.30%。Neonc Technologies Holdings, Inc.公司简介：NeOnc Technologies Holdings Inc. 是一种新型分子技术的开发商，提供增强靶向技术来治疗中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091022423397862163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091022423397862163&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","NTHI","GLTO"],"gpt_icon":0},{"id":"1129847890","title":"NeOnc Technologies获得FDA批准进入Neo212二期临床试验——首创口服化学共轭化疗药物用于脑癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1129847890","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129847890?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:01","pubTimestamp":1757509277,"startTime":"0","endTime":"0","summary":"NeOnc Technologies获得美国食品药品监督管理局(FDA)授权，将推进Neo212的二期临床试验。Neo212是一款首创的口服化学共轭化疗候选药物，专门用于脑癌治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neonctech.com","stockEarnings":[{"period":"1week","weight":0.0261},{"period":"1month","weight":-0.0358},{"period":"3month","weight":-0.0032},{"period":"6month","weight":-0.0348},{"period":"1year","weight":-0.6232},{"period":"ytd","weight":0.1391}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0195},{"period":"3month","weight":-0.0151},{"period":"6month","weight":0.0297},{"period":"1year","weight":0.208},{"period":"ytd","weight":-0.007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neonc Technologies Holdings, Inc.于2023年1月5日注册成立，为特拉华州公司。作为一家临床阶段的生物制药公司，该公司一直专注于建立颅内恶性肿瘤的治疗方法，即位于大脑的侵袭性癌症。这些癌症类型包括原发性脑癌，如胶质母细胞瘤，和继发性脑癌，它们是通过全身其他癌症的转移扩散而来的，如黑色素瘤或乳腺癌和肺癌。大脑局限性恶性肿瘤特别难以治疗，因为血脑屏障阻止了大多数药物治疗剂有效进入大脑。因此，这些患者面临着预后不良和平均预期寿命缩短的问题。NeOnc正在开发新的药物递送方法，用于与新的候选药物联合使用。","exchange":"NASDAQ","name":"NeOnc Technologies Holdings","nameEN":"NeOnc Technologies Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeOnc Technologies Holdings(NTHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeOnc Technologies Holdings(NTHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeOnc Technologies Holdings,NTHI,NeOnc Technologies Holdings股票,NeOnc Technologies Holdings股票老虎,NeOnc Technologies Holdings股票老虎国际,NeOnc Technologies Holdings行情,NeOnc Technologies Holdings股票行情,NeOnc Technologies Holdings股价,NeOnc Technologies Holdings股市,NeOnc Technologies Holdings股票价格,NeOnc Technologies Holdings股票交易,NeOnc Technologies Holdings股票购买,NeOnc Technologies Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeOnc Technologies Holdings(NTHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeOnc Technologies Holdings(NTHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}